|
Sign In to gain access to subscriptions and/or personal tools.
|
Antitumoral Activity Induced by Alkylating Agents Conjugated to Poly(maleic anhydride-alt-vinyl acetate)
Marcel Popa
Department of Natural and Synthetic Polymers, "Gh.Asachi" Technical University of Ia i, Bd. D. Mangeron, No 71 A, 700050 Ia i, Romania, marpopa{at}ch.tuiasi.ro
Valeriu Sunel
Department of Organic Chemistry, "Al.I.Cuza" University of Ia i, Bd. Carol No 11, 700506, Ia i, Romania
Nicoleta Dulea
Department of Organic Chemistry, "Al.I.Cuza" University of Ia i, Bd. Carol No 11, 700506, Ia i, Romania
Aura Angelica Popa
"Petre Andrei" University, Str. Ghica Voda, No. 13, 700400, Iasi, Romania
Raphael M. Ottenbrite
Virginia Commonwealth University, Richmond, USA
Constantin V. Uglea
Department of Biomedical Engineering, University of Medicine and Pharmacy, Str. Universitatii 16, 700015 Iasi, Romania
New polyanionic polymer conjugates with antitumoral activity are synthesized by chemically binding mustard type alkylating derivatives of di-(ß-chloroethyl)-amine and tri-(ß-chloroethyl)-amine, respectively, onto poly(maleic anhydride-alt-vinyl acetate). The structures of the compounds are verified by FTIR, 1H NMR, and elemental analysis. The antitumoral activity of these polymeric drugs is evaluated in vivo using carcinosarcoma Walker 256 solid tumors in Wister rats. The conjugates exhibit antitumor regression (ATR) values between 25 and 44% depending on comonomers' structure. In addition, an accumulation in the solid tumors (enhanced permeability and retention (EPR) effect) by these compounds is observed. These compounds also cause small organotropic effects, such as increases in the liver, spleen, and kidney weight.
Key Words: poly(maleic anhydride-alt-vinyl acetate) tri-(ß-chloroethyl)-amine di-(ß-chloroethyl)-amine antitumoral activity bioactive polymers carcinosarcoma Walker 256 tumors.
References
-
 unel, V. and  oldea, C. (1995). Indian J. Chem., 34(B): 227—229. -
 unel, V., Popa, M., Popa, A. and  oldea, C. (2000). Cellulose Chemistry and Technology, 34: 269—274. - Xie, G., Gupta, R. and Lown, J.W. (1995). Anti Cancer Drug Design, 10(1): 389—409.
- Gupta, R., Wang, H., Huang, L. and Lown, J.W. (1995). Anti Cancer Drug Design, 10(1): 25—41.
-
 unel, V. and  oldea, C. (1993). Comp. Rend. Acad. Bulg. Sci., 46: 61—63.[CrossRef] - Sunel, V., Cecal, A., Soldea, C. and Asandei, N. (1995). Rev. Roumaine de chimie, 40: 763—768.
- Janson, P.E., Kenne, L. and Linberg, B. (1975). Carbohydr. Res., 45: 275—282.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Popa, M.,
 unel, V. and B l it -Rusu, L. (2003). Journal of Biomaterials Applications, 18: 83—94.[Abstract/Free Full Text] - Dumitriu, S. and Popa, M. (1988). Makromolekulare Chemie, 189: 103—110.[CrossRef]
- Butler, G.B. (1980). In: Donaruma, L.G., Ottenbrite, R.M. and Vogi, O. (eds), Anionic Polymer Drugs, p. 39, John Wiley, New York.
- Ottenbrite, R.M., Regelson, W., Kaplan, A., Carchman, R., Morahan, P. and Munson, A. (1978). In: Donaruma, L.G., Ottenbrite, R.M. and Vogi, O. (eds), Polymer Drugs, John Wiley, New York.
- Uglea, C.V., Vatajanu, A., Offenberg, H., Grecianu, A., Ottenbrite, R.M. and Negulescu, I.I. (1993). Polymer, 34: 3298—3301.[CrossRef][Web of Science]
- Culbertson, B.M. (1987). Maleic and Fumaric Polymers, In: Encycl. Polym. Sci. Eng., 2nd edn, Vol 14, pp. 225—294, John Wiley and Sons, New York.
- Patel, H., Raval, D.A., Madamwar, D. and Patel, S.R. (1997). Angew. Makromol. Chem., 245: 1—8.[CrossRef]
- Patel, H., Raval, D.A., Madamwar, D. and Patel, S.P. (1998). Angew. Makromol. Chem., 263: 25—30.[CrossRef]
- Lee, Y.S. and Byoun, Y.S. (2002). Bull. Korean Chem. Soc., 23: 1833—1835; (2001). J. Ind. Eng. Chem., 7: 310—317.
- Jeong, J.H., Byoum, Y.S. and Lee, Y.S. (2002). Reactive and Functional Polymers, 50: 257—263.[CrossRef]
- Uglea, C., Parv, A., Dumitriu, A., Corjan, M. and Ottenbrite, R. (2006). J. Bioact. Compat. Polym., 21(5): 399—413.[Abstract/Free Full Text]
- Sunel, V., Popa, M., Dumitriu, C.L., Ciobanu, A., Bunia, I. and Popa, A.A. (2005). Reactive and Functional Polymers, 65(3): 367—380.[CrossRef]
- Bacu, E., Chitanu, G.C., Couture, A., Grandclaudon, P., Singurel, Gh. and Carpov, A. (2002). European Polymer Journal, 38: 1509—1513.[CrossRef][Web of Science]
- Pollak, V.A. and Fidler, I.J. (1982). J. Natl. Cancer Inst., 69: 137—141.[Web of Science][Medline]
[Order article via Infotrieve]
- Markaverich, B.M., Gregory, R.R., Alejandrov, M.A., Johnson, G.A. and Middledich, B.S. (1998). J. High Resolut. Chromatoyc., Chromatogr. Commun., 11: 605—607.
- Brown, R.R., Bain, R. and Jordan, V.C. (1983). J. Chromatogr., 272: 351—356.[Web of Science][Medline]
[Order article via Infotrieve]
- Uglea, C.V., Panaitescu, L., Spiridon, D., Ursu, D., Popa, I. and Ottenbrite, R.M. (1996). J. Biomater. Sci. Polymer Edn., 8: 269—280.
- Panaitescu, L. and Ottenbrite, R.M. (2002). J. Bioact. Compat. Polymers, 17: 367—373.
- Ringsdorf, H., Schlarb, B. and VBentmer, J. (1988). Angew. Chem. Int. Ed. Engls., 27: 113—139.[CrossRef]
- Matsumura, Y. and Maeda, H. (1986). Cancer Res., 46: 6387—6391.[Abstract/Free Full Text]
- Maeda, H., Seymour, L. and Miyamoto, Y. (1992). Bioconjugate Chem., 3: 351—359.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Maeda, H. (1992). J. Controlled Rel., 19: 315—321.[CrossRef][Web of Science]
- Uglea, C.V., Pârv, A., Corjan, M., Dumitriu, A. and Ottenbrite, R.M. (2005). J. Bioact. Compat. Polymers, 20: 571—583.[CrossRef]
- Thatte, S., Datar, K. and Ottenbrite, R.M. (2005). J. Bioact. Compat. Polym., 20(6): 585—601.[Abstract]
- Chiellini, F. (2006). Journal of Bioactive and Compatible Polymers, 21: 257—271.[CrossRef]
- Jacob, L.S. (1992). Pharmacology, Chap 11. 3rd edn, National Medical Series, Williams and Wilkins, Baltimore.
Journal of Bioactive and Compatible Polymers, Vol. 22, No. 6,
651-666 (2007)
DOI: 10.1177/0883911507084424

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S.-M. Lee, B.-G. Kim, C.-S. Ha, I. Chung, and Dong Xie
Syntheses and Evaluations of Antitumor and Antiangiogenic Compounds Conjugated with 5-Fluorouracil and Ascorbic Acid
Journal of Bioactive and Compatible Polymers,
September 1, 2008;
23(5):
473 - 489.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Bayram, E. B. Denkbas, E. Kilicay, B. Hazer, H. B. Cakmak, and I. Noda
Preparation and Characterization of Triamcinolone Acetonide-loaded Poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) (PHBHx) Microspheres
Journal of Bioactive and Compatible Polymers,
July 1, 2008;
23(4):
334 - 347.
[Abstract]
[PDF]
|
 |
|
|
|